Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer

Published:2014-03-28 Issue:6 Volume:23 Page:809-821
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Fasano Morena,Della Corte Carminia Maria,Califano Raffaele,Capuano Annalisa,Troiani Teresa,Martinelli Erika,Ciardiello Fortunato,Morgillo Floriana

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/13543784.2014.902934

Reference61 articles.

1. Cancer statistics, 2012

2. Oncogene Addiction

3. The Concept of Synthetic Lethality in the Context of Anticancer Therapy

4. Tumor Angiogenesis

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allosteric site identification, virtual screening and discovery of a sulfonamide Hsp110-STAT3 interaction inhibitor for the treatment of hypoxic pulmonary arterial hypertension;European Journal of Medicinal Chemistry;2024-12

2. In silico and in vitro evaluation of novel carbothioamide-based and heterocyclic derivatives of 4-(tert-butyl)-3-methoxybenzoic acid as EGFR tyrosine kinase allosteric site inhibitors;Results in Chemistry;2024-01

3. Harnessing allosteric inhibition: prioritizing LIMK2 inhibitors for targeted cancer therapy through pharmacophore-based virtual screening and essential molecular dynamics;Journal of Biomolecular Structure and Dynamics;2023-12-08

4. Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications;MedComm;2023-05-02

5. Molecular Docking, Molecular Dynamics Simulation, and Analysis of EGFR-derived Peptides against the EGF;Letters in Drug Design & Discovery;2023-02-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3